Cargando…

Molecular targets of Yangyin Fuzheng Jiedu Prescription in the treatment of hepatocellular carcinoma based on network pharmacology analysis

BACKGROUND: Yangyin Fuzheng Jiedu Prescription (YFJP) is a traditional Chinese medicine (TCM) indicated for the treatment of hepatocellular carcinoma (HCC). Its potential targets and molecular mechanisms are not clear. Therefore, this study intends to explore the molecular mechanism of YFJP based on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Fengna, Feng, Miaomiao, Wang, Xinhui, Wang, Peng, Xie, Yuqing, Liu, Xiaoli, Li, Weihong, Yang, Zhiyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650191/ https://www.ncbi.nlm.nih.gov/pubmed/33292207 http://dx.doi.org/10.1186/s12935-020-01596-y

Ejemplares similares

Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma
por: Xie, Yuqing, et al.
Publicado: (2022)

Network Pharmacology Interpretation of Fuzheng–Jiedu Decoction against Colorectal Cancer
por: Shi, Hongshuo, et al.
Publicado: (2021)

Yangyin Fuzheng Decoction enhances anti-tumor efficacy of cisplatin on lung cancer
por: Wei, Dongmei, et al.
Publicado: (2018)

Study on Mechanism of Yiqi Yangyin Jiedu Recipe Inhibiting Triple Negative Breast Cancer Growth: A Network Pharmacology and In Vitro Verification
por: Sun, Xin, et al.
Publicado: (2022)

Efficacy of Yiqi Yangyin Jiedu decoction in postoperative patients with thyroid cancer: A protocol for systematic review and meta-analysis
por: Li, Qiao, et al.
Publicado: (2022)

In Vitro Antibacterial Experiment of Fuzheng Jiedu Huayu Decoction Against Multidrug-Resistant Pseudomonas aeruginosa
por: Xu, Hongri, et al.
Publicado: (2020)

Fuzheng Kang-Ai decoction enhances the effect of Gefitinib-induced cell apoptosis in lung cancer through mitochondrial pathway
por: Wang, Sumei, et al.
Publicado: (2020)

A network pharmacology and bioinformatics exploration of the possible molecular mechanisms of Fuzheng Xiaoliu Granule for the treatment of hepatocellular carcinoma
por: Fan, Tianyu, et al.
Publicado: (2023)

Exploration of Fuzheng Yugan Mixture on COVID-19 based on network pharmacology and molecular docking
por: Jiang, Xinyu, et al.
Publicado: (2023)

Spectrum-Effect Relationship between HPLC Fingerprints and Antioxidant Activity of Yangyin Tongnao Prescription
por: Yu, Li, et al.
Publicado: (2021)

Molecular mechanisms of Huanglian jiedu decoction on ulcerative colitis based on network pharmacology and molecular docking
por: Yang, Jing, et al.
Publicado: (2022)

Antiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia
por: Wang, Xinhui, et al.
Publicado: (2021)

Exploring the Potential Mechanism of Xiaokui Jiedu Decoction for Ulcerative Colitis Based on Network Pharmacology and Molecular Docking
por: Wang, Bin, et al.
Publicado: (2021)

Investigating the cardioprotective effects of Fuzheng Yangxin recipe based on network pharmacology and experimental evaluation
por: Wang, Anzhu, et al.
Publicado: (2022)

Pharmacological mechanisms of Fuzheng Huayu formula for Aristolochic acid I–induced kidney fibrosis through network pharmacology
por: Wang, Fan, et al.
Publicado: (2022)

A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy
por: Zhou, Dongdong, et al.
Publicado: (2021)

Decoding the Mechanism of Huanglian Jiedu Decoction in Treating Pneumonia Based on Network Pharmacology and Molecular Docking
por: Li, Xianhai, et al.
Publicado: (2021)

TIGIT(+) TIM-3(+) NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma
por: Yu, Lihua, et al.
Publicado: (2021)

Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma
por: Wang, Peng, et al.
Publicado: (2023)

Integrating Network Pharmacology and Experimental Validation to Elucidate the Mechanism of Yiqi Yangyin Decoction in Suppressing Non-Small-Cell Lung Cancer
por: Jiao, Pengfei, et al.
Publicado: (2023)

Study on Intervention Mechanism of Yiqi Huayu Jiedu Decoction on ARDS Based on Network Pharmacology
por: Liang, Xu, et al.
Publicado: (2020)

Based on the Network Pharmacology to Investigate the Mechanism of Qingjie Fuzheng Granules against Colorectal Cancer
por: Fang, Yi, et al.
Publicado: (2022)

Molecular Mechanism of the Effect of Huanglian Jiedu Decoction on Type 2 Diabetes Mellitus Based on Network Pharmacology and Molecular Docking
por: Yin, Bei, et al.
Publicado: (2020)

Network pharmacology and molecular docking analysis on molecular targets and mechanism prediction of Huanglian Jiedu Decoction in the treatment of COVID-19
por: Xinyi, Xu, et al.
Publicado: (2022)

Study on the Mechanism of Huanglian Jiedu Decoction in Treating Dyslipidemia Based on Network Pharmacology
por: Gong, Zhaohui, et al.
Publicado: (2022)

Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of Huanglian Jiedu Decoction in Treating Atherosclerosis
por: Liang, Jiahua, et al.
Publicado: (2021)

Potential Targets and Mechanisms of Jiedu Quyu Ziyin Decoction for Treating SLE-GIOP: Based on Network Pharmacology and Molecular Docking
por: Li, Jie, et al.
Publicado: (2023)

Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy
por: Yu, Lihua, et al.
Publicado: (2022)

Evaluating the role of RAD52 and its interactors as novel potential molecular targets for hepatocellular carcinoma
por: Li, Ping, et al.
Publicado: (2019)

Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools
por: Xiong, Haijun, et al.
Publicado: (2020)

Molecular mechanisms of Huanglian Jiedu decoction in treating Alzheimer’s disease by regulating microbiome via network pharmacology and molecular docking analysis
por: Zheng, Renyuan, et al.
Publicado: (2023)

Mechanistic Insights of Qingre Jiedu Recipe Based on Network Pharmacology Approach against Heart Failure
por: Li, Xuan, et al.
Publicado: (2022)

Synergisic effect of APRIL knockdown and Jiedu Xiaozheng Yin, a Chinese medicinal recipe, on the inhibition of hepatocellular carcinoma cell proliferation
por: Liu, Zhizhen, et al.
Publicado: (2017)

Analysis of the active components and mechanism of Shufeng Jiedu capsule against COVID-19 based on network pharmacology and molecular docking
por: Simayi, Jimilihan, et al.
Publicado: (2022)

Multitarget and Multipathway Regulation of Zhenqi Fuzheng Granule against Non-Small Cell Lung Cancer Based On Network Pharmacology and Molecular Docking
por: Zhou, Yanqing, et al.
Publicado: (2022)

FOXC2 is a prognostic biomarker and contributes to the growth and invasion of human hepatocellular carcinoma
por: Chen, Jinzhang, et al.
Publicado: (2020)

Effect and Molecular Mechanisms of Jiedu Recipe on Hypoxia-Induced Angiogenesis after Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma
por: Lin, Wanfu, et al.
Publicado: (2021)

Dynamic Protective Effect of Chinese Herbal Prescription, Yiqi Jiedu Decoction, on Testis in Mice with Acute Radiation Injury
por: Wang, Tian-Qi, et al.
Publicado: (2021)

Chinese Herbal Medicine (Yiqi-Yangyin-Jiedu Decoction) Combined With Osimertinib as First-Line Treatment in EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer (CATLA-2): A Study Protocol for a Double-Blind Randomized Controlled Trial
por: Yao, Jialin, et al.
Publicado: (2022)

Integrating Network Pharmacology and Experimental Models to Investigate the Mechanism of Huanglian Jiedu Decoction on Inflammatory Injury Induced by Cerebral Ischemia
por: Li, HuiMin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_em97ppsn2ntmbb13lueocab5ur